文献速递多重用药老年慢病共病管理

住院老年人潜在不适当处方模式与药物不良反应的性别差异:SENATOR试验发现

Sex differences in patterns of potentially inappropriate prescribing and adverse drug reactions in hospitalized older people: Findings from the SENATOR trial.
PubMed 文献 · J Am Geriatr Soc · 2024-07-09

本研究为SENATOR临床试验数据库的回顾性二次分析,纳入1537例多病共病住院老年人(女性47.2%,中位年龄78岁),探讨潜在不适当处方与药物不良反应(ADR)的性别差异。结果显示女性发生≥1次ADR的比例显著高于男性(28% vs 21%),且多数具有显著性别差异的STOPP标准潜在不适当用药(PIM)和START标准潜在处方遗漏(PPO)在女性中更常见。

要点

  • 住院老年女性发生≥1次ADR的比例显著高于男性(28% vs 21%)。
  • 11项显示显著性别差异的STOPP标准PIM中9项在女性中更常见。
  • 4项显示显著性别差异的START标准PPO全部在女性中更常见。

核心结论

  • 住院老年女性中特定STOPP标准PIM和START标准PPO的检出率高于男性,可能促成女性ADR发生率更高。
  • 处方者应认识到潜在不适当处方暴露和ADR风险存在性别差异。

研究设计与样本

  • SENATOR临床试验数据库的回顾性二次分析,覆盖欧洲6个大型医学中心。
  • 纳入1537例多病共病住院老年人,女性占47.2%,中位年龄78岁(IQR 72-84)。
  • 分析入院48小时内识别的PIM和PPO(依据STOPP/START第2版标准)及入院或出院后14天内识别的ADR。

主要发现

  • 住院期间女性发生≥1次ADR的比例为28%,男性为21%(OR 1.40,95%CI 1.10-1.78,p<0.005)。
  • 11项显示显著性别差异的STOPP标准PIM中9项在女性中更常见。
  • 4项显示显著性别差异的START标准PPO全部在女性中更常见。
  • 部分与性别相关的PIM反映了老年女性中相关疾病患病率更高。

关键数值与推荐

  • PIM和PPO依据STOPP/START第2版标准定义。
  • ADR由盲法终点裁定小组共识评估。

临床怎么用

  • 对住院老年女性处方时应特别关注STOPP标准PIM和START标准PPO,以降低ADR风险。
  • 鉴于多数临床环境中老年女性占多数,处方者应重视潜在不适当处方和ADR风险的性别差异。

局限性

  • 本研究为临床试验数据库的回顾性二次分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Older women experience more adverse drug reactions (ADRs) than older men. However, the underlying basis for this sex difference is unclear. Sex (biological status) and/or gender (sociocultural constructs) influences on patterns of inappropriate prescribing in multimorbid older adults may be one reason for this ADR sex difference. In this secondary analysis, we examined whether incident ADR sex differences could be related to concurrent sex differences in potentially inappropriate prescribing. DESIGN AND SETTING: A retrospective secondary analysis of sex differences in the prevalence of potentially inappropriate medications (PIMs), potential prescribing omissions (PPOs), and ADRs among the 1537 participants (47.2% female, median [IQR] age 78 [72-84] years) was undertaken in the SENATOR clinical trial database, conducted in six large European medical centers. PARTICIPANTS AND METHODS: We looked specifically for male/female differences relating to PIMs and PPOs (defined by STOPP/START version 2 criteria) identified within 48 h of acute hospitalization. We also assessed sex differences for ADRs identified at 14 days from admission or discharge, whichever came first. ADRs were assessed by blinded endpoint adjudication panel consensus. RESULTS: During hospitalization, significantly more females experienced ≥1 ADR compared to males (28% and 21%, respectively; odds ratio 1.40, 95% CI 1.10-1.78, p < 0.005). Nine of the 11 STOPP-criteria PIMs showing a significant sex difference occurred more often in females. Of the four START-criteria PPOs showing a significant sex difference, all occurred more often in females. Some sex-associated PIMs reflect higher prevalence of related conditions in older women. CONCLUSION: We conclude that specific STOPP-criteria PIMs and START-criteria PPOs were identified more frequently in older women than older men during acute hospitalization, possibly contributing to higher ADR incidence in older women. Prescribers should appreciate sex differences in exposure to potentially inappropriate prescribing and ADR risk, given the preponderance of older women over older men in most clinical settings.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. O'Mahony D, Cruz-Jentoft AJ, Gudmundsson A, et al. Sex differences in patterns of potentially inappropriate prescribing and adverse drug reactions in hospitalized older people: Findings from the SENATOR trial. J Am Geriatr Soc. 2024. PMID: 38979859. doi:10.1111/jgs.19071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。